H43-33163-77494
3 vaccinations
4 coded responses
28 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 946 / CA
- Registered
- 2021-11-18
- Relationship
- Child or adolescent in my care
- Guardian
- HQK-28721-82714
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-13
Dose 1 — Pfizer-BioNTech
-
2021-11-18
Registered in v-safe
-
2021-11-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-11-19
- 2021-11-20
- 2021-11-28
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-04
-
2021-12-05
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Sneezing — Feeling: FairFree text: SneezingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-06
-
2021-12-07
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-08
-
2021-12-09
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Itching · NoneAdult check-in
-
2021-12-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Itching · NoneAdult check-in
- 2021-12-11
- 2021-12-18
-
2021-12-25
Survey response — day 21, dose 2, dependentMedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Previous history of kidney cyst, grew in sizeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Report sent to call center — day 21, dose 2, dependentGet care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-12-27
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-03-05
-
2022-05-27
Dose 3 — Pfizer-BioNTech
-
2022-06-02
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · HeadacheAdult check-in
- 2022-06-03
- 2022-06-10
- 2022-06-19
- 2022-06-24
-
2022-07-01
Survey response — day 35, dose 3, dependentMedDRA: Pain, SARS-CoV-2 test positive, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: Positive CoVID test, with sneezing and body achesMedDRA releases: 2024-11 · check-in free text available
- 2022-07-08
- 2022-08-26
-
2022-11-25
Survey response — 6 months, dose 3, dependentMedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Frequent fever, cough and runny noseMedDRA releases: 2024-11 · check-in free text available
- 2023-05-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-13 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-05-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Sneezing
Release 10 — day 21, dose 2, dependent
Symptoms: Previous history of kidney cyst, grew in size
Release 12 — day 35, dose 3, dependent
Symptoms: Positive CoVID test, with sneezing and body aches
Release 12 — 6 months, dose 3, dependent
Symptoms: Frequent fever, cough and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release